Many of the life sciences trends that are driving innovation today were here pre-COVID, but the pandemic was an accelerant. This is true of the vaccine research that is moving at rapid speed to curb this acute global crisis, but it doesn’t stop there. The same tide is lifting all areas of the life sciences industry. This is particularly true for advanced therapy medicinal products.
The pandemic is pushing the envelope on speed-to-market to the point that facility design and construction may be experiencing a paradigm shift. The tried-and-true approach needs to be revisited as Operation Warp Speed is demanding the biopharmaceutical industry to navigate uncharted territory.
During this webinar, we will highlight lessons learned from a Warp Speed project and provide advice and new approaches on how to apply these lessons to the future of ATMP manufacturing.
Attendees will learn about:
- Challenges and solutions from a COVID-19 Warp Speed project
- Code, safety and regulatory considerations to keep your project on track
- Practical advice to apply as the future of our industry navigates a paradigm shift
James P Bornholdt
CRB
JP Bornholdt is the Director of Global SlateXpace Operations at CRB. He creates pre-eminent solutions for the life science industry by working with project teams to apply innovative and disruptive approaches such as flexible design strategies, scalable turn-key technologies, modular, offsite fabricated, and integrated project deliveries. Licensed as both an architect and engineer, his expert knowledge of multiple disciplines provides a strong basis for integrated facility design and construction.
Charles Heffernan
Director at CRB
Thomas Page
Vice President - Engineering & Asset Development at Fujifilm Diosynth Biotechnologies
Jarrod Wrampe
Process Utility Engineer at CRB